Clinical trial
Pegylated Interferon to Treat Chronic Hepatitis D
NCT00023322 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00023322 |
|---|---|
| Title | Pegylated Interferon to Treat Chronic Hepatitis D |
| Official title | Treatment of Chronic Delta Hepatitis With Pegylated Interferon |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis D |
| Intervention type | Drug |
| Interventions | Peginterferon Alpha-2a |
| Enrollment | 13 |
| Start date | Aug 1, 2001 |
| Primary completion | May 1, 2012 |
| Completion | Oct 1, 2012 |
| First posted | Sep 3, 2001 |
| Last update posted | Jul 10, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: